[Tolerance and safety of anti-Helicobacter drugs in the treatment of ulcer disease].
132 patients (mean age 46.9 +/- 1.4 years) with exacerbation of gastroduodenal ulcer (GDU) positive by Helicobacter pylori (HP) were examined clinically and using laboratory tests. All the patients received treatment with anti-HP drugs. Side effects were registered in 81(61.4%) patients. Negative trend in colon biocenosis occurred in all the patients. The treatment was poorly tolerated by women, aged patients and those with ulcer in the stomach. Biocenosis aggravation is indication for administration of eubiotics.
Artamonov
V E
VE
Masharova
A A
AA
Gorodetskiĭ
V V
VV
Vertkin
A L
AL
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000898:Antibiosis / Q000187:drug effects; D001341:Autonomic Nervous System / Q000187:drug effects; D003106:Colon / Q000187:drug effects / Q000382:microbiology; D004064:Digestive System / Q000187:drug effects* / Q000294:innervation; D004415:Dyspepsia / Q000139:chemically induced*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents